NCT06834477

Brief Summary

The purpose of this research is to investigate the impact of structural abnormalities and microenvironmental changes in the olfactory cleft on olfactory function in patients with chronic rhinosinusitis (CRS). It sought to elucidate the complex relationships among structural abnormalities, microenvironmental changes, and inflammatory factors contributing to olfactory dysfunction through a multidimensional assessment encompassing imaging, aerodynamics, biomarker , and histopathology analysis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Mar 2025Mar 2027

First Submitted

Initial submission to the registry

February 6, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 19, 2025

Completed
23 days until next milestone

Study Start

First participant enrolled

March 14, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2027

Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

2 years

First QC Date

February 6, 2025

Last Update Submit

February 13, 2025

Conditions

Keywords

olfactory cleftolfactory dysfunction

Outcome Measures

Primary Outcomes (1)

  • Sniffin Sticks Test

    The test consists of odorous rods that are presented to the patient's nose. It consists of 3 parts different, with 3 sets of corresponding sticks: an olfactory threshold test, an olfactory discrimination test and an olfactory identification test. The final TDI score, out of 48, is the sum of the olfactory threshold, discrimination and identification scores.

    Immediately before surgery

Secondary Outcomes (12)

  • The 22-item Sino-Nasal Outcome Test (SNOT-22)

    Immediately before surgery

  • Visual analog scale(VAS)for olfaction

    Immediately before surgery

  • The Questionnaire of Olfactory Disorders Negative Statements (QOD-NS)

    Immediately before surgery

  • The original version of olfactory cleft CT score

    during routine preoperative CT imaging

  • The modified version of olfactory cleft CT score

    during routine preoperative CT imaging

  • +7 more secondary outcomes

Study Arms (2)

Patients with CRS admitted for endoscopic sinus surgery

Other: Computed Tomography

healthy controls undergoing surgery for the deviated septum

Other: Computed Tomography

Interventions

low-dose CT is taken

Also known as: collection of superior turbinate biopsy specimens, collection of olfactory cleft mucus
Patients with CRS admitted for endoscopic sinus surgeryhealthy controls undergoing surgery for the deviated septum

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Surgical patients were recruited from the Department of Otolaryngology at Peking University Third Hospital in clinic.

You may qualify if:

  • Diagnosed with CRS based on the diagnostic criteria of the EPOS guideline.
  • Provision of signed and dated informed consent form.
  • Patients with CRS admitted to the hospital awaiting endoscopic sinus surgery.
  • Healthy controls undergoing surgery for the deviated septum.
  • Provision of signed and dated informed consent form.

You may not qualify if:

  • Those who have taken oral glucocorticoids, antibiotics, anti-leukotrienes, and antihistamines within four weeks.
  • Patients who have had prior sinus surgery.
  • Patients with fungal sinusitis, inverted papilloma, or other nasal diseases.
  • Patients with a diagnosis of immune suppression or suspicion of malignancy that may be affecting the nose/paranasal sinuses.
  • Patients who are mentally or physically unable to perform olfactory tests
  • Patients with nasal polyps, sinusitis, nasal cavity tumors and other diseases.
  • Patients with hyposmia or anosmia.
  • Patients with diagnosed neurodegenerative disease.
  • Patients who are mentally or physically unable to perform olfactory tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Otolaryngology Head and Neck Surgery, Peking University Third Hospital, Beijing, People's Republic of China

Beijing, Haidian District, 10019, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

Mucus from the olfactory cleft and biopsy specimens from the posterior end of the superior turbinate

Central Study Contacts

Dawei Wu, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Researcher

Study Record Dates

First Submitted

February 6, 2025

First Posted

February 19, 2025

Study Start

March 14, 2025

Primary Completion (Estimated)

March 14, 2027

Study Completion (Estimated)

March 14, 2027

Last Updated

February 19, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

We will decide whether to share the individual participant data after the study.

Locations